Sandbox Reserved 1716
From Proteopedia
(Difference between revisions)
| Line 7: | Line 7: | ||
[[Image:VKORimage3.png|400px|right|thumb|Figure 1. Closed Conformation of VKOR due to Warfarin Binding]] | [[Image:VKORimage3.png|400px|right|thumb|Figure 1. Closed Conformation of VKOR due to Warfarin Binding]] | ||
===Vitamin K Cycle=== | ===Vitamin K Cycle=== | ||
| + | Vitamin K Epoxide Reductase has a large role in the Vitamin K Cycle. The vitamin K Cycle, and the VKOR enzyme are common drug targets for thromboembolic diseases. This is because, as pictured, the vitamin K cycle is the process in which blood coagulant factors II, VII, IX, and X are activated. This promotes blood clotting, which can be dangerous and cause thromboembolic diseases such as stroke, deep vein thrombosis, and/or pulmonary embolism. | ||
===Location of Enzyme === | ===Location of Enzyme === | ||
== Structure == | == Structure == | ||
Revision as of 15:13, 24 March 2022
Vitamin K Epoxide Reductase
| |||||||||||
References
- ↑ Ransey E, Paredes E, Dey SK, Das SR, Heroux A, Macbeth MR. Crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme EhDbr1 reveals a catalytic Zn(2+) /Mn(2+) heterobinucleation. FEBS Lett. 2017 Jul;591(13):2003-2010. doi: 10.1002/1873-3468.12677. Epub 2017, Jun 14. PMID:28504306 doi:http://dx.doi.org/10.1002/1873-3468.12677
